Healthcare tech to navigate the new normal DIGITAL REPORT 2020
02
03
HEALTHCARE TECH TO NAVIGATE THE NEW NORMAL
www.l tt s . com
L&T TECHNOLOGY SERVICES
Jyotirmay Datta (JD), EVP & Business Head at LTTS, tells us about his company’s place in the new, post-Covid medical industry
T 04
he Covid-19 pandemic has brought about a paradigm shift in the healthcare industry. All players, from medical device
manufacturers to healthcare providers to medical practitioners, have been forced to rethink the very fundamentals of how their work is performed. In a wide-ranging interview, Jyotirmay Datta (JD), EVP and Business Head at LTTS, speaks about the ways that his organization can play an important role in the positive changes that healthcare businesses are enacting, to prepare the medical industry for the post-Covid world.
GETTING THE PRODUCT MIX RIGHT FOR THE POST-COVID WORLD JD explains that due to postponement of elective procedures, much lower visits to Outpatients departments and low utilization of ER, every part of the Healthcare industry is disrupted by COVID19. However, the level of disruption is different for
05
www.l tt s . com
Listen to the Podcast here
L&T TECHNOLOGY SERVICES
“ We have a role in the life-cycle of each product, from its design to the time it is introduced to the market” 08
— Jyotirmay Datta, EVP & Business Head, Healthcare Industry Vertical, L&T Technology Services Ltd (LTTS)
different players. One consequence is that hospitals are reducing their spend on medical equipment to conserve cash while significantly increase allocation of funds to upgrade their telehealth capabilities. This is affecting all device OEMs to varying degrees depending on their product mix, but all of them are trying to reduce their expenditure in the short term. This is where LTTS comes in: to help organizations to adapt their product mix to suit hospitals’ new requirements, and to do so in a cost-effective way. He pinpoints accelerating R&D, particularly
A Day With L&T Technology Services CLICK TO WATCH
|
1:47
09
fight against Covid-19, as a key space
WORKING TOGETHER TO STREAMLINE DIAGNOSTICS
for LTTS to grow in, as well as sup-
One of the biggest demands on the
porting their manufacturing and supply
medical industry in recent months has
chains, and supporting the producers
been to improve the speed of diagnosis,
with regulatory approvals.
while not compromising on the accu-
for the products in demand for the
“The top medical device companies
racy of tests. JD is confident that the
all reflect a very similar sentiment,”
healthcare industry can accomplish
says JD. “When we look at the pharma
this - and is certain that LTTS can help.
and health insurance companies, there
He mentions that effective diagnos-
have been very little impact on them.
tics requires effective collaboration
So, they are continuing to perform
between OEMs, clinical trials organiza-
well, revenues are growing and bottom
tions, regulatory agencies and different
lines are still very healthy”.
healthcare bodies. With wide-ranging www.l tt s . com
L&T TECHNOLOGY SERVICES
Telehealth Product Transformation for a leading OEM CLICK TO WATCH
|
2:12
10
experience in diagnostics and regula-
the testing and the validation process
tory affairs, LTTS is well placed to
for some of this equipment that is being
expedite testing and validation of the
tested by the OEMs. We also are helping
new solutions that are tabled, can offer
with the manufacturing capacity as well.
services for regulatory submissions,
We have a role in the life-cycle of each
and can help to enhance their manufac-
product, from its design to the time it is
turing capacity.
introduced to the market.”
“The OEMs, clinical trials organizabodies, healthcare bodies - to make
IMPROVED REMOTE CARE THE SILVER LINING
sure that R&D happens in a very efficient
Another key area for LTTS is remote
manner they all have to coordinate and
patient care. This issue is even more
collaborate very well,” continues JD. “In
essential considering the challenges
the near term, LTTS is helping expedite
posed by Covid-19. JD feels that here,
tions, regulatory agencies, government
too, LTTS has a role to play in supporting healthcare providers.
“Now, as a result of Covid-19, regulations have been eased by CDC and
“If there is one positive outcome of this
HHS for more than 80 telehealth-based
life-changing event, it is the massively
procedures. CMS has approved them
increased adoption of telehealth and
for Medicare, and other insurance
remote care solutions,” he says. “If we
companies have agreed for reimburse-
were to rewind the last six months, some
ments. As a result, providers have rolled
of the major issues standing in the way
them out in greater numbers. Patients
of greater adoption of telehealth were
have adopted them like never before:
regulatory approvals for most of the
in some of the larger health systems,
procedures, insurance reimbursements
telehealth transactions have gone from
for telehealth-based treatments, and
a few thousand per month to tens of
security concerns.
thousands per week.” 11
E X E C U T I V E P R O FILE :
Jyotirmay Datta Title: EVP and CBO
Company: L&T Technology Services
Industry: Healthcare Jyotirmay Datta (JD) is the EVP and CBO - Healthcare at L&T Technology Services and heads the Medical Devices Business with P&L responsibility for LTTS’ businesses across Med-Tech, Lifesciences and Healthcare customers. With 30 years of experience in the Technology and Healthcare industries, JD specialize in shaping, nurturing and leading businesses that serve the needs of Med-Tech & Lifesciences companies and Healthcare providers in improving access, efficacy and outcome of Connected Care across the care pathway. www.l tt s . com
L&T TECHNOLOGY SERVICES
SUPPLY CHAIN DISRUPTION: A PROBLEM OR AN OPPORTUNITY? One challenge to the healthcare industry that is still causing anxiety amongst its stakeholders is disruptions to the supply chain. LTTS is one of the companies that is helping medical device manufacturers to relocate their manufacturing plants, adding new manufacturing lines, and enabling higher operational efficiency to ensure supply of critical medical equipment to the healthcare providers is continued. 12
“I n some of the larger health systems, telehealth transactions have gone from a few thousand per month to tens of thousands per week” — Jyotirmay Datta, EVP & Business Head, Healthcare Industry Vertical, L&T Technology Services Ltd (LTTS)
Finding alternative sites and adapting to a new supply chain is complex: medtech manufacturing locations, JD explains, are spread across the USA, Europe and Asia. As per JD, Medtech companies are seriously evaluating their strategy for expansion in South
for the company’s iBEMS platform,
Asia including India. This is offering
an innovative, cloud-based building
opportunities for LTTS.
experience management system of systems that allows individual systems
THE IBEMS PLATFORM: THE SHIELD TO KEEP PATIENTS AND HEALTHCARE STAFF SAFE
to each other. This solution can also
JD also sees an opportunity for LTTS
spaces healthy for air quality, social
to make hospitals a more harmoni-
distancing and temperature monitor-
ous place in the post-Covid world. He
ing. JD paints the picture of a hospital
explains that it is the perfect moment
experience that is entirely touchless.
in the hospital to intelligently connect now upgraded to keep the hospital
13
“Let’s try to visualize how this may
in the pathological and imaging labs,
play out,” says JD. “A patient enters
information can be communicated
the hospital and is greeted by a robot.
via gestures. Technologies that guide
A thermal detection is done; their face
the patient without requiring any con-
image is captured, their symptoms are
tact have become so important for
entered using IT, and then the patient
making sure the environment is safe
is directed by the wayfinder to the
and healthy.”
relevant medical officer. Medications are then ordered online and delivered to the patient’s home. Touch screens can be replaced by voices; www.l tt s . com
P0WERED BY
www.ltts.com